Acurx Pharmaceuticals Inc (NASDAQ:ACXP) shares traded -12.27% lower at $0.72 on Wall Street last session.
ACXP stock price is now 84.74% away from the 50-day moving average and -27.99% away from the 200-day moving average. The market capitalization of the company currently stands at $16.91M.
In other news, Scodari Joseph C, Director bought 24,631 shares of the company’s stock on Jan 06 ’25. The stock was bought for $25,000 at an average price of $1.01. Upon completion of the transaction, the Director now directly owns 27,708 shares in the company, valued at $19949.76. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 06 ’25, Director Sailer Carl bought 24,631 shares of the business’s stock. A total of $25,000 was incurred on buying the stock at an average price of $1.01. This leaves the insider owning 137,183 shares of the company worth $98771.76. A total of 13.17% of the company’s stock is owned by insiders.
During the past 12 months, Acurx Pharmaceuticals Inc has had a low of $0.30 and a high of $3.33. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 1.93, and a quick ratio of 1.93. The fifty day moving average price for ACXP is $0.38976 and a two-hundred day moving average price translates $0.999945 for the stock.
The latest earnings results from Acurx Pharmaceuticals Inc (NASDAQ: ACXP) was released for 2025-03-31.
